Results
20,303 records
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 13 |  Kurtz GeorgeDirector, PRESIDENT AND CEO |  CRWDCrowdStrike Holdings, Inc.Open-market sale · 10b5-1 plan | SELL | $26K 120 sh | Sep 11, 2026 traded Sep 10, 2026 | |
Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 13 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $26K 120 sh | Sep 11, 2026 traded Sep 10, 2026 | |
Kurtz GeorgeDirector, PRESIDENT AND CEO |
| CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan |
| SELL |
| $41K 200 sh |
| Sep 11, 2026 traded Sep 10, 2026 |
| 11 | Perez Daniel AntonioDirector, CEO & Co-Founder, 10% Owner |  HNGEHinge Health, Inc.Open-market sale · 10b5-1 plan | SELL | $149K 1,630 sh | Sep 11, 2026 traded Sep 10, 2026 |
| 11 | Perez Daniel AntonioDirector, CEO & Co-Founder, 10% Owner | HNGEHinge Health, Inc. Open-market sale · 10b5-1 plan | SELL | $101K 1,100 sh | Sep 11, 2026 traded Sep 10, 2026 |
| 10 |  Sahin UgurChief Executive Officer, 10% Owner |  BNTXBioNTech SEOpen-market sale · 10b5-1 plan | SELL | $1.97M 20.5K sh | Sep 11, 2026 traded Sep 10, 2026 |
| 8 | Musunuri ShankarDirector, Chief Executive Officer |  OCGNOcugen, Inc.Open-market sale · 10b5-1 plan | SELL | $64K 57.3K sh | Sep 11, 2026 traded Sep 9, 2026 |
| 7 | Sibold William JohnDirector, President and CEO |  MDGLMADRIGAL PHARMACEUTICALS, INC.Open-market sale · 10b5-1 plan | SELL | $558K 1,040 sh | Sep 11, 2026 traded Sep 9, 2026 |
| 7 | Sibold William JohnDirector, President and CEO | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $280K 520 sh | Sep 11, 2026 traded Sep 9, 2026 |
| 7 | Sibold William JohnDirector, President and CEO | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $344K 640 sh | Sep 11, 2026 traded Sep 9, 2026 |
| 7 | Sibold William JohnDirector, President and CEO | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $345K 644 sh | Sep 11, 2026 traded Sep 9, 2026 |
| 7 | Sibold William JohnDirector, President and CEO | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $277K 522 sh | Sep 11, 2026 traded Sep 9, 2026 |
| 7 | Sibold William JohnDirector, President and CEO | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $273K 512 sh | Sep 11, 2026 traded Sep 9, 2026 |
| 7 | Sibold William JohnDirector, President and CEO | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $273K 505 sh | Sep 11, 2026 traded Sep 9, 2026 |
| 5 | Gracey CraigChief Accounting Officer |  OMDAOmada Health, Inc.Open-market sale · 10b5-1 plan | SELL | $14K 644 sh | Sep 11, 2026 traded Sep 9, 2026 |
| 4 | Sibold William JohnDirector, President and CEO | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $87K 160 sh | Sep 11, 2026 traded Sep 9, 2026 |
| 4 | Sibold William JohnDirector, President and CEO | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $371K 687 sh | Sep 11, 2026 traded Sep 11, 2026 |
| 4 | Sibold William JohnDirector, President and CEO | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $837K 1,539 sh | Sep 11, 2026 traded Sep 11, 2026 |
| 4 | Sibold William JohnDirector, President and CEO | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $652K 1,202 sh | Sep 11, 2026 traded Sep 11, 2026 |
| 4 | Sibold William JohnDirector, President and CEO | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $184K 347 sh | Sep 11, 2026 traded Sep 9, 2026 |
| 4 | Sibold William JohnDirector, President and CEO | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $69K 131 sh | Sep 11, 2026 traded Sep 9, 2026 |
| 4 | Sibold William JohnDirector, President and CEO | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $212K 396 sh | Sep 11, 2026 traded Sep 9, 2026 |
| 4 | Sibold William JohnDirector, President and CEO | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $116K 215 sh | Sep 11, 2026 traded Sep 9, 2026 |
| 4 | Sibold William JohnDirector, President and CEO | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $196K 368 sh | Sep 11, 2026 traded Sep 9, 2026 |
| 4 | Sibold William JohnDirector, President and CEO | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $196K 362 sh | Sep 11, 2026 traded Sep 9, 2026 |
| 4 | Sibold William JohnDirector, President and CEO | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $415K 761 sh | Sep 11, 2026 traded Sep 11, 2026 |
| 3 | Brosius MarkEVP & Chief Mfg and Supply Cha |  ISRGINTUITIVE SURGICAL INCOpen-market sale · 10b5-1 plan | SELL | $9,145 25 sh | Sep 11, 2026 traded Sep 11, 2026 |
| 3 | Brosius MarkEVP & Chief Mfg and Supply Cha | ISRGINTUITIVE SURGICAL INC Open-market sale · 10b5-1 plan | SELL | $7,996 23 sh | Sep 11, 2026 traded Sep 10, 2026 |
| 1 | Arora TarunChief Accounting Officer |  RNGRingCentral, Inc.Open-market sale · 10b5-1 plan | SELL | $190K 2,679 sh | Sep 11, 2026 traded Sep 9, 2026 |
| 1 | Sibold William JohnDirector, President and CEO | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $199K 368 sh | Sep 11, 2026 traded Sep 11, 2026 |
| 1 | Arora TarunChief Accounting Officer | RNGRingCentral, Inc. Open-market sale · 10b5-1 plan | SELL | $104K 1,493 sh | Sep 11, 2026 traded Sep 9, 2026 |
| 1 | Sibold William JohnDirector, President and CEO | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $86K 160 sh | Sep 11, 2026 traded Sep 11, 2026 |
| 1 | Sibold William JohnDirector, President and CEO | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $66K 120 sh | Sep 11, 2026 traded Sep 11, 2026 |
| 1 | Sibold William JohnDirector, President and CEO | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $57K 106 sh | Sep 11, 2026 traded Sep 11, 2026 |
| 1 | Sibold William JohnDirector, President and CEO | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $117K 218 sh | Sep 11, 2026 traded Sep 11, 2026 |
| 0 | Sibold William JohnDirector, President and CEO | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $32K 60 sh | Sep 11, 2026 traded Sep 11, 2026 |
| 0 | Azar Samak LChief Legal Officer |  GFSGLOBALFOUNDRIES Inc.Open-market sale · 10b5-1 plan | SELL | $15K 335 sh | Sep 11, 2026 traded Sep 10, 2026 |
| 51 | Jubran SamiEVP Chief Finance Officer |  ZIMZIM Integrated Shipping Services Ltd.Open-market sale | SELL | $55K 1,824 sh | Sep 10, 2026 traded Sep 8, 2026 |
| 48 | Jubran SamiEVP Chief Finance Officer | ZIMZIM Integrated Shipping Services Ltd. Open-market sale | SELL | $36K 1,196 sh | Sep 10, 2026 traded Sep 8, 2026 |
| 44 | Intrator Michael NDirector, CEO and President, 10% Owner |  CRWVCoreWeave, Inc.Open-market sale · 10b5-1 plan | SELL | $3.08M 29.9K sh | Sep 10, 2026 traded Sep 8, 2026 |
| 42 |  Gilbert Ray Cisneros, Jr.DSelf |  NETCloudflare, Inc.Partial sale | SELL | $1,001 – $15K | Sep 10, 2026 traded Aug 18, 2026 |